{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:26:56Z","timestamp":1791487616672,"version":"4.3.4"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81373149"],"award-info":[{"award-number":["81373149"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Fund of the Gusu Health Talents Project","award":["GSWS2019054"],"award-info":[{"award-number":["GSWS2019054"]}]},{"name":"The Fund of Collaborative Innovation Center of Bone and Immunity between Sihong Hospital and Soochow University","award":["The Fund of Collaborative Innovation Center of Bone and Immunity between Sihong Hospital and Soochow University"],"award-info":[{"award-number":["The Fund of Collaborative Innovation Center of Bone and Immunity between Sihong Hospital and Soochow University"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08148-4","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T17:25:00Z","timestamp":1776533100000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Upregulation of CSN8 induces a unique senescence-like state with robust tumor-promoting properties in epithelial ovarian cancer cells under hypoxia"],"prefix":"10.1186","volume":"24","author":[{"given":"Mengyuan","family":"Ruan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxue","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronglin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songguang","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghuan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunyu","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8821-6820","authenticated-orcid":false,"given":"Songwen","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,18]]},"reference":[{"key":"8148_CR1","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.annonc.2023.07.011","volume":"34","author":"A Gonz\u00e1lez-Mart\u00edn","year":"2023","unstructured":"Gonz\u00e1lez-Mart\u00edn A, Harter P, Leary A, Lorusso D, Miller RE, Pothuri B, et al. Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34:833\u201348.","journal-title":"Ann Oncol"},{"key":"8148_CR2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41392-020-0134-x","volume":"5","author":"J Fares","year":"2020","unstructured":"Fares J, Fares MY, Khachfe HH, Salhab HA, Fares Y. Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduct Target Ther. 2020;5:28.","journal-title":"Signal Transduct Target Ther"},{"key":"8148_CR3","doi-asserted-by":"publisher","first-page":"viii51","DOI":"10.1093\/annonc\/mdx441","volume":"28","author":"S Pignata","year":"2017","unstructured":"Pignata S, Du Bois SCC, Harter A, Heitz P. Treatment of recurrent ovarian cancer. Ann Oncol. 2017;28:viii51\u20136.","journal-title":"Ann Oncol"},{"key":"8148_CR4","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cancergen.2024.06.002","volume":"286\u2013287","author":"D Sonkin","year":"2024","unstructured":"Sonkin D, Thomas A, Teicher BA. Cancer treatments: Past, present, and future. Cancer Genet. 2024;286\u2013287:18\u201324.","journal-title":"Cancer Genet"},{"key":"8148_CR5","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41571-022-00668-4","volume":"19","author":"CA Schmitt","year":"2022","unstructured":"Schmitt CA, Wang B, Demaria M. Senescence and cancer - role and therapeutic opportunities. Nat Rev Clin Oncol. 2022;19:619\u201336.","journal-title":"Nat Rev Clin Oncol"},{"key":"8148_CR6","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1038\/s12276-021-00717-5","volume":"53","author":"SS Park","year":"2021","unstructured":"Park SS, Choi YW, Kim JH, Kim HS, Park TJ. Senescent tumor cells: an overlooked adversary in the battle against cancer. Exp Mol Med. 2021;53:1834\u201341.","journal-title":"Exp Mol Med"},{"key":"8148_CR7","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41581-022-00601-z","volume":"18","author":"W Huang","year":"2022","unstructured":"Huang W, Hickson LJ, Eirin A, Kirkland JL, Lerman LO. Cellular senescence: the good, the bad and the unknown. Nat Rev Nephrol. 2022;18:611\u201327.","journal-title":"Nat Rev Nephrol"},{"key":"8148_CR8","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1016\/S0962-8924(01)82148-6","volume":"11","author":"J Campisi","year":"2001","unstructured":"Campisi J. Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol. 2001;11:S27\u201331.","journal-title":"Trends Cell Biol"},{"key":"8148_CR9","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nature05327","volume":"444","author":"R Di Micco","year":"2006","unstructured":"Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, Luise C, et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature. 2006;444:638\u201342.","journal-title":"Nature"},{"key":"8148_CR10","doi-asserted-by":"crossref","unstructured":"Ohtani N. The roles and mechanisms of senescence-associated secretory phenotype (SASP): can it be controlled by senolysis? Inflamm Regen. 2022;42:11.","DOI":"10.1186\/s41232-022-00197-8"},{"key":"8148_CR11","doi-asserted-by":"crossref","unstructured":"Kim YH, Choi YW, Lee J, Soh EY, Kim JH, Park TJ. Senescent tumor cells lead the collective invasion in thyroid cancer. Nat Commun. 2017;8:15208.","DOI":"10.1038\/ncomms15208"},{"key":"8148_CR12","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1111\/febs.16381","volume":"290","author":"M Takasugi","year":"2023","unstructured":"Takasugi M, Yoshida Y, Hara E, Ohtani N. The role of cellular senescence and SASP in tumour microenvironment. FEBS J. 2023;290:1348\u201361.","journal-title":"FEBS J"},{"key":"8148_CR13","doi-asserted-by":"publisher","first-page":"2002497","DOI":"10.1002\/advs.202002497","volume":"8","author":"YW Choi","year":"2021","unstructured":"Choi YW, Kim YH, Oh SY, Suh KW, Kim YS, Lee GY, et al. Senescent Tumor Cells Build a Cytokine Shield in Colorectal Cancer. Adv Sci (Weinh). 2021;8:2002497.","journal-title":"Adv Sci (Weinh)"},{"key":"8148_CR14","doi-asserted-by":"crossref","unstructured":"Ray SK, Mukherjee S. Exploring replication stress and cellular senescence as key targets in novel cancer therapies. Cancer Genet. 2025;298\u20139:78\u201387.","DOI":"10.1016\/j.cancergen.2025.09.002"},{"key":"8148_CR15","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12943-025-02284-z","volume":"24","author":"B Liu","year":"2025","unstructured":"Liu B, Peng Z, Zhang H, Zhang N, Liu Z, Xia Z, et al. Regulation of cellular senescence in tumor progression and therapeutic targeting: mechanisms and pathways. Mol Cancer. 2025;24:106.","journal-title":"Mol Cancer"},{"key":"8148_CR16","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/s42003-021-02257-0","volume":"4","author":"K Santos-de-Frutos","year":"2021","unstructured":"Santos-de-Frutos K, Djouder N. When dormancy fuels tumour relapse. Commun Biol. 2021;4:747.","journal-title":"Commun Biol"},{"key":"8148_CR17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","volume":"8","author":"Z Chen","year":"2023","unstructured":"Chen Z, Han F, Du Y, Shi H, Zhou W. Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2023;8:70.","journal-title":"Signal Transduct Target Ther"},{"key":"8148_CR18","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s13046-021-02035-0","volume":"40","author":"D Otero-Albiol","year":"2021","unstructured":"Otero-Albiol D, Carnero A. Cellular senescence or stemness: hypoxia flips the coin. J Exp Clin Cancer Res. 2021;40:243.","journal-title":"J Exp Clin Cancer Res"},{"key":"8148_CR19","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1038\/sj.emboj.7600196","volume":"23","author":"M Koshiji","year":"2004","unstructured":"Koshiji M, Kageyama Y, Pete EA, Horikawa I, Barrett JC, Huang LE. HIF-1alpha induces cell cycle arrest by functionally counteracting Myc. EMBO J. 2004;23:1949\u201356.","journal-title":"EMBO J"},{"key":"8148_CR20","doi-asserted-by":"publisher","first-page":"7919","DOI":"10.1074\/jbc.M010189200","volume":"276","author":"LB Gardner","year":"2001","unstructured":"Gardner LB, Li Q, Park MS, Flanagan WM, Semenza GL, Dang CV. Hypoxia inhibits G1\/S transition through regulation of p27 expression. J Biol Chem. 2001;276:7919\u201326.","journal-title":"J Biol Chem"},{"key":"8148_CR21","doi-asserted-by":"publisher","first-page":"573","DOI":"10.20892\/j.issn.2095-3941.2021.0605","volume":"19","author":"W Du","year":"2022","unstructured":"Du W, Zhang R, Muhammad B, Pei D. Targeting the COP9 signalosome for cancer therapy. Cancer Biol Med. 2022;19:573\u201390.","journal-title":"Cancer Biol Med"},{"key":"8148_CR22","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12943-020-01285-4","volume":"19","author":"S Ju","year":"2020","unstructured":"Ju S, Wang F, Wang Y. CSN8 is a key regulator in hypoxia-induced epithelial-mesenchymal transition and dormancy of colorectal cancer cells. Mol Cancer. 2020;19:168.","journal-title":"Mol Cancer"},{"key":"8148_CR23","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1006\/excr.1997.3560","volume":"233","author":"Y Yaginuma","year":"1997","unstructured":"Yaginuma Y, Hayashi H, Kawai K, Kurakane T, Saitoh Y, Kitamura S, et al. Analysis of the Rb gene and cyclin-dependent kinase 4 inhibitor genes (p16INK4 and p15INK4B) in human ovarian carcinoma cell lines. Exp Cell Res. 1997;233:233\u20139.","journal-title":"Exp Cell Res"},{"key":"8148_CR24","doi-asserted-by":"publisher","first-page":"R453","DOI":"10.1016\/j.cub.2014.03.034","volume":"24","author":"M Schieber","year":"2014","unstructured":"Schieber M, Chandel NS. ROS function in redox signaling and oxidative stress. Curr Biol. 2014;24:R453\u2013462.","journal-title":"Curr Biol"},{"key":"8148_CR25","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/s41423-023-01061-6","volume":"20","author":"M Bied","year":"2023","unstructured":"Bied M, Ho WW, Ginhoux F, Bl\u00e9riot C. Roles of macrophages in tumor development: a spatiotemporal perspective. Cell Mol Immunol. 2023;20:983\u201392.","journal-title":"Cell Mol Immunol"},{"key":"8148_CR26","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","volume":"14","author":"A Mantovani","year":"2017","unstructured":"Mantovani A, Marchesi F, Malesci A, Laghi L, Allavena P. Tumour-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol. 2017;14:399\u2013416.","journal-title":"Nat Rev Clin Oncol"},{"key":"8148_CR27","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/nature08815","volume":"464","author":"HK Lin","year":"2010","unstructured":"Lin HK, Chen Z, Wang G, Nardella C, Lee SW, Chan CH, et al. Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence. Nature. 2010;464:374\u20139.","journal-title":"Nature"},{"key":"8148_CR28","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1146\/annurev.cellbio.19.111301.112449","volume":"19","author":"N Wei","year":"2003","unstructured":"Wei N, Deng XW. The COP9 signalosome. Annu Rev Cell Dev Biol. 2003;19:261\u201386.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"8148_CR29","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12943-022-01645-2","volume":"21","author":"R Bai","year":"2022","unstructured":"Bai R, Li Y, Jian L, Yang Y, Zhao L, Wei M. The hypoxia-driven crosstalk between tumor and tumor-associated macrophages: mechanisms and clinical treatment strategies. Mol Cancer. 2022;21:177.","journal-title":"Mol Cancer"},{"key":"8148_CR30","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41514-024-00138-4","volume":"10","author":"V Lelarge","year":"2024","unstructured":"Lelarge V, Capelle R, Oger F, Mathieu T. Le Calv\u00e9 B. Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients\u2019 treatment. NPJ Aging. 2024;10:12.","journal-title":"NPJ Aging"},{"key":"8148_CR31","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.critrevonc.2019.05.014","volume":"140","author":"D Luvero","year":"2019","unstructured":"Luvero D, Plotti F, Aloisia A, Montera R, Terranova C, De Carlo N, et al. Ovarian cancer relapse: From the latest scientific evidence to the best practice. Crit Rev Oncol Hematol. 2019;140:28\u201338.","journal-title":"Crit Rev Oncol Hematol"},{"key":"8148_CR32","doi-asserted-by":"publisher","first-page":"3616","DOI":"10.1128\/MCB.21.11.3616-3631.2001","volume":"21","author":"K Alexander","year":"2001","unstructured":"Alexander K, Hinds PW. Requirement for p27(KIP1) in retinoblastoma protein-mediated senescence. Mol Cell Biol. 2001;21:3616\u201331.","journal-title":"Mol Cell Biol"},{"key":"8148_CR33","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.cmet.2005.05.001","volume":"1","author":"RD Guzy","year":"2005","unstructured":"Guzy RD, Hoyos B, Robin E, Chen H, Liu L, Mansfield KD, et al. Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab. 2005;1:401\u20138.","journal-title":"Cell Metab"},{"key":"8148_CR34","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.yexcr.2015.03.011","volume":"334","author":"H Wang","year":"2015","unstructured":"Wang H, Zhang X, Teng L, Legerski RJ. DNA damage checkpoint recovery and cancer development. Exp Cell Res. 2015;334:350\u20138.","journal-title":"Exp Cell Res"},{"key":"8148_CR35","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1172\/JCI95148","volume":"128","author":"N Herranz","year":"2018","unstructured":"Herranz N, Gil J. Mechanisms and functions of cellular senescence. J Clin Invest. 2018;128:1238\u201346.","journal-title":"J Clin Invest"},{"key":"8148_CR36","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1111\/cas.15068","volume":"112","author":"H Nakamura","year":"2021","unstructured":"Nakamura H, Takada K. Reactive oxygen species in cancer: Current findings and future directions. Cancer Sci. 2021;112:3945\u201352.","journal-title":"Cancer Sci"},{"key":"8148_CR37","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1158\/0008-5472.CAN-18-3437","volume":"79","author":"T Saleh","year":"2019","unstructured":"Saleh T, Tyutyunyk-Massey L, Gewirtz DA. Tumor Cell Escape from Therapy-Induced Senescence as a Model of Disease Recurrence after Dormancy. Cancer Res. 2019;79:1044\u20136.","journal-title":"Cancer Res"},{"key":"8148_CR38","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1158\/2159-8290.CD-20-1808","volume":"11","author":"L Bejarano","year":"2021","unstructured":"Bejarano L, Jord\u0101o MJC, Joyce JA. Therapeutic Targeting of the Tumor Microenvironment. Cancer Discov. 2021;11:933\u201359.","journal-title":"Cancer Discov"},{"key":"8148_CR39","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.gendis.2023.02.039","volume":"11","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Xing C, Deng Y, Ye C, Peng H. HIF-1\u03b1 signaling: Essential roles in tumorigenesis and implications in targeted therapies. Genes Dis. 2024;11:234\u201351.","journal-title":"Genes Dis"},{"key":"8148_CR40","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med. 2018;24:541\u201350.","journal-title":"Nat Med"},{"key":"8148_CR41","doi-asserted-by":"publisher","first-page":"940","DOI":"10.3389\/fimmu.2020.00940","volume":"11","author":"A Labani-Motlagh","year":"2020","unstructured":"Labani-Motlagh A, Ashja-Mahdavi M, Loskog A. The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses. Front Immunol. 2020;11:940.","journal-title":"Front Immunol"},{"key":"8148_CR42","doi-asserted-by":"publisher","first-page":"692142","DOI":"10.3389\/fonc.2021.692142","volume":"11","author":"AER Kartikasari","year":"2021","unstructured":"Kartikasari AER, Huertas CS, Mitchell A, Plebanski M. Tumor-Induced Inflammatory Cytokines and the Emerging Diagnostic Devices for Cancer Detection and Prognosis. Front Oncol. 2021;11:692142.","journal-title":"Front Oncol"},{"key":"8148_CR43","doi-asserted-by":"publisher","first-page":"1026954","DOI":"10.3389\/fimmu.2022.1026954","volume":"13","author":"C Kerneur","year":"2022","unstructured":"Kerneur C, Cano CE, Olive D. Major pathways involved in macrophage polarization in cancer. Front Immunol. 2022;13:1026954.","journal-title":"Front Immunol"},{"key":"8148_CR44","doi-asserted-by":"publisher","first-page":"15642","DOI":"10.1073\/pnas.1519644112","volume":"112","author":"B Luan","year":"2015","unstructured":"Luan B, Yoon YS, Le Lay J, Kaestner KH, Hedrick S, Montminy M. CREB pathway links PGE2 signaling with macrophage polarization. Proc Natl Acad Sci U S A. 2015;112:15642\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8148_CR45","doi-asserted-by":"publisher","first-page":"e70090","DOI":"10.1002\/eji.70090","volume":"55","author":"M Pfirrmann","year":"2025","unstructured":"Pfirrmann M, B\u00f6dder J, Wuestenenk R, Tennebroek J, Lyer KK, Poel D, et al. The Phenotypical and Functional Effect of PGE2 on Human Macrophages. Eur J Immunol. 2025;55:e70090.","journal-title":"Eur J Immunol"},{"key":"8148_CR46","doi-asserted-by":"publisher","first-page":"667177","DOI":"10.3389\/fimmu.2021.667177","volume":"12","author":"E Li","year":"2021","unstructured":"Li E, Yang X, Du Y, Wang G, Chan DW, Wu D, et al. CXCL8 Associated Dendritic Cell Activation Marker Expression and Recruitment as Indicators of Favorable Outcomes in Colorectal Cancer. Front Immunol. 2021;12:667177.","journal-title":"Front Immunol"},{"key":"8148_CR47","doi-asserted-by":"publisher","first-page":"1103149","DOI":"10.3389\/fonc.2023.1103149","volume":"13","author":"Z Zou","year":"2023","unstructured":"Zou Z, Lin H, Li M, Lin B. Tumor-associated macrophage polarization in the inflammatory tumor microenvironment. Front Oncol. 2023;13:1103149.","journal-title":"Front Oncol"},{"key":"8148_CR48","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41698-024-00522-z","volume":"8","author":"S Wang","year":"2024","unstructured":"Wang S, Wang J, Chen Z, Luo J, Guo W, Sun L, et al. Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance. NPJ Precis Oncol. 2024;8:31.","journal-title":"NPJ Precis Oncol"},{"key":"8148_CR49","doi-asserted-by":"crossref","unstructured":"Zhao Y, Caron C, Chan YY, Lee CK, Xu X, Zhang J et al. cis-B7:CD28 interactions at invaginated synaptic membranes provide CD28 co-stimulation and promote CD8(+) T cell function and anti-tumor immunity. Immun. 2023;56:1187\u2013e12031112.","DOI":"10.1016\/j.immuni.2023.04.005"},{"key":"8148_CR50","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1038\/srep03793","volume":"4","author":"T Zhao","year":"2014","unstructured":"Zhao T, Zhu Y, Morinibu A, Kobayashi M, Shinomiya K, Itasaka S, et al. HIF-1-mediated metabolic reprogramming reduces ROS levels and facilitates the metastatic colonization of cancers in lungs. Sci Rep. 2014;4:3793.","journal-title":"Sci Rep"},{"key":"8148_CR51","doi-asserted-by":"publisher","first-page":"101109","DOI":"10.1016\/j.redox.2019.101109","volume":"25","author":"HS Li","year":"2019","unstructured":"Li HS, Zhou YN, Li L, Li SF, Long D, Chen XL, et al. HIF-1\u03b1 protects against oxidative stress by directly targeting mitochondria. Redox Biol. 2019;25:101109.","journal-title":"Redox Biol"},{"key":"8148_CR52","doi-asserted-by":"publisher","first-page":"6683","DOI":"10.1158\/0008-5472.CAN-06-0425","volume":"66","author":"A Kaidi","year":"2006","unstructured":"Kaidi A, Qualtrough D, Williams AC, Paraskeva C. Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia. Cancer Res. 2006;66:6683\u201391.","journal-title":"Cancer Res"},{"key":"8148_CR53","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1158\/1541-7786.MCR-10-0506","volume":"9","author":"HH Al-Khalaf","year":"2011","unstructured":"Al-Khalaf HH, Hendrayani SF, Aboussekhra A. The atr protein kinase controls UV-dependent upregulation of p16INK4A through inhibition of Skp2-related polyubiquitination\/degradation. Mol Cancer Res. 2011;9:311\u20139.","journal-title":"Mol Cancer Res"},{"key":"8148_CR54","doi-asserted-by":"publisher","first-page":"189","DOI":"10.14348\/molcells.2014.2353","volume":"37","author":"H Jing","year":"2014","unstructured":"Jing H, Lee S. NF-\u03baB in cellular senescence and cancer treatment. Mol Cells. 2014;37:189\u201395.","journal-title":"Mol Cells"},{"key":"8148_CR55","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/jmcb\/mjy012","volume":"10","author":"K Liu","year":"2018","unstructured":"Liu K, Zhang L, Zhao Q, Zhao Z, Zhi F, Qin Y, et al. SKP2 attenuates NF-\u03baB signaling by mediating IKK\u03b2 degradation through autophagy. J Mol Cell Biol. 2018;10:205\u201315.","journal-title":"J Mol Cell Biol"},{"key":"8148_CR56","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.bbagrm.2014.03.013","volume":"1849","author":"G Bretones","year":"2015","unstructured":"Bretones G, Delgado MD, Le\u00f3n J. Myc and cell cycle control. Biochim Biophys Acta. 2015;1849:506\u201316.","journal-title":"Biochim Biophys Acta"},{"key":"8148_CR57","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.1073\/pnas.0600069103","volume":"103","author":"I Guney","year":"2006","unstructured":"Guney I, Wu S, Sedivy JM. Reduced c-Myc signaling triggers telomere-independent senescence by regulating Bmi-1 and p16(INK4a). Proc Natl Acad Sci U S A. 2006;103:3645\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8148_CR58","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ccr.2007.07.006","volume":"12","author":"JD Gordan","year":"2007","unstructured":"Gordan JD, Thompson CB, Simon MC. HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation. Cancer Cell. 2007;12:108\u201313.","journal-title":"Cancer Cell"},{"key":"8148_CR59","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/S1097-2765(03)00193-X","volume":"11","author":"N von der Lehr","year":"2003","unstructured":"von der Lehr N, Johansson S, Wu S, Bahram F, Castell A, Cetinkaya C, et al. The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription. Mol Cell. 2003;11:1189\u2013200.","journal-title":"Mol Cell"},{"key":"8148_CR60","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/S1097-2765(02)00520-8","volume":"9","author":"O Vafa","year":"2002","unstructured":"Vafa O, Wade M, Kern S, Beeche M, Pandita TK, Hampton GM, et al. c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. Mol Cell. 2002;9:1031\u201344.","journal-title":"Mol Cell"},{"key":"8148_CR61","doi-asserted-by":"publisher","first-page":"6598","DOI":"10.1158\/0008-5472.CAN-05-3115","volume":"66","author":"S Ray","year":"2006","unstructured":"Ray S, Atkuri KR, Deb-Basu D, Adler AS, Chang HY, Herzenberg LA, et al. MYC can induce DNA breaks in vivo and in vitro independent of reactive oxygen species. Cancer Res. 2006;66:6598\u2013605.","journal-title":"Cancer Res"},{"key":"8148_CR62","doi-asserted-by":"publisher","first-page":"6040","DOI":"10.1158\/0008-5472.CAN-18-0980","volume":"78","author":"NT Moldogazieva","year":"2018","unstructured":"Moldogazieva NT, Lutsenko SV, Terentiev AA. Reactive Oxygen and Nitrogen Species-Induced Protein Modifications: Implication in Carcinogenesis and Anticancer Therapy. Cancer Res. 2018;78:6040\u20137.","journal-title":"Cancer Res"},{"key":"8148_CR63","doi-asserted-by":"publisher","first-page":"3814","DOI":"10.1038\/s41467-019-11772-y","volume":"10","author":"SV Faull","year":"2019","unstructured":"Faull SV, Lau AMC, Martens C, Ahdash Z, Hansen K, Yebenes H, et al. Structural basis of Cullin 2 RING E3 ligase regulation by the COP9 signalosome. Nat Commun. 2019;10:3814.","journal-title":"Nat Commun"},{"key":"8148_CR64","doi-asserted-by":"crossref","unstructured":"Li Z, Wang D, Messing EM, Wu G. VHL protein-interacting deubiquitinating enzyme 2 deubiquitinates and stabilizes HIF\u20101\u03b1. EMBO Rep. 2005;6.","DOI":"10.1038\/sj.embor.7400377"},{"key":"8148_CR65","doi-asserted-by":"publisher","first-page":"5362","DOI":"10.1093\/emboj\/19.20.5362","volume":"19","author":"C Wirbelauer","year":"2000","unstructured":"Wirbelauer C, Sutterl\u00fcty H, Blondel M, Gstaiger M, Peter M, Reymond F, et al. The F-box protein Skp2 is a ubiquitylation target of a Cul1-based core ubiquitin ligase complex: evidence for a role of Cul1 in the suppression of Skp2 expression in quiescent fibroblasts. EMBO J. 2000;19:5362\u201375.","journal-title":"EMBO J"},{"key":"8148_CR66","doi-asserted-by":"publisher","first-page":"20443","DOI":"10.1074\/jbc.M113.468959","volume":"288","author":"C Liu","year":"2013","unstructured":"Liu C, Guo LQ, Menon S, Jin D, Pick E, Wang X, et al. COP9 signalosome subunit Csn8 is involved in maintaining proper duration of the G1 phase. J Biol Chem. 2013;288:20443\u201352.","journal-title":"J Biol Chem"},{"key":"8148_CR67","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.molcel.2007.06.013","volume":"27","author":"V Amador","year":"2007","unstructured":"Amador V, Ge S, Santamar\u00eda PG, Guardavaccaro D, Pagano M. APC\/C(Cdc20) controls the ubiquitin-mediated degradation of p21 in prometaphase. Mol Cell. 2007;27:462\u201373.","journal-title":"Mol Cell"},{"key":"8148_CR68","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1111\/febs.16350","volume":"290","author":"L Zhang","year":"2023","unstructured":"Zhang L, Pitcher LE, Prahalad V, Niedernhofer LJ, Robbins PD. Targeting cellular senescence with senotherapeutics: senolytics and senomorphics. FEBS J. 2023;290:1362\u201383.","journal-title":"FEBS J"},{"key":"8148_CR69","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/s41568-022-00450-9","volume":"22","author":"L Wang","year":"2022","unstructured":"Wang L, Lankhorst L, Bernards R. Exploiting senescence for the treatment of cancer. Nat Rev Cancer. 2022;22:340\u201355.","journal-title":"Nat Rev Cancer"},{"key":"8148_CR70","doi-asserted-by":"publisher","first-page":"204062232096412","DOI":"10.1177\/2040622320964125","volume":"11","author":"M Zhu","year":"2020","unstructured":"Zhu M, Meng P, Ling X, Zhou L. Advancements in therapeutic drugs targeting of senescence. Ther Adv Chronic Dis. 2020;11:2040622320964125.","journal-title":"Ther Adv Chronic Dis"},{"key":"8148_CR71","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s13045-021-01197-w","volume":"14","author":"Z Jiang","year":"2021","unstructured":"Jiang Z, Sun H, Yu J, Tian W, Song Y. Targeting CD47 for cancer immunotherapy. J Hematol Oncol. 2021;14:180.","journal-title":"J Hematol Oncol"},{"key":"8148_CR72","doi-asserted-by":"crossref","unstructured":"Li J, Dong T, Wu Z, Zhu D, Gu H. The effects of MYC on tumor immunity and immunotherapy. Cell Death Discov. 2023;9:103.","DOI":"10.1038\/s41420-023-01403-3"},{"key":"8148_CR73","doi-asserted-by":"crossref","unstructured":"Li W, Wang F, Guo R, Bian Z, Song Y. Targeting macrophages in hematological malignancies: recent advances and future directions. J Hematol Oncol. 2022;15:110.","DOI":"10.1186\/s13045-022-01328-x"},{"key":"8148_CR74","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1158\/1541-7786.MCR-20-0956","volume":"19","author":"A Shimizu","year":"2021","unstructured":"Shimizu A, Sawada K, Kobayashi M, Yamamoto M, Yagi T, Kinose Y, et al. Exosomal CD47 Plays an Essential Role in Immune Evasion in Ovarian Cancer. Mol Cancer Res. 2021;19:1583\u201395.","journal-title":"Mol Cancer Res"},{"key":"8148_CR75","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.canlet.2015.02.036","volume":"360","author":"Z Xiao","year":"2015","unstructured":"Xiao Z, Chung H, Banan B, Manning PT, Ott KC, Lin S, et al. Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma. Cancer Lett. 2015;360:302\u20139.","journal-title":"Cancer Lett"},{"key":"8148_CR76","doi-asserted-by":"publisher","first-page":"1292053","DOI":"10.3389\/fragi.2023.1292053","volume":"4","author":"T Shreeya","year":"2023","unstructured":"Shreeya T, Ansari MS, Kumar P, Saifi M, Shati AA, Alfaifi MY, et al. Senescence: A DNA damage response and its role in aging and Neurodegenerative Diseases. Front Aging. 2023;4:1292053.","journal-title":"Front Aging"},{"issue":"Suppl 1","key":"8148_CR77","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0959-8049(09)70036-X","volume":"45","author":"GM DeNicola","year":"2009","unstructured":"DeNicola GM, Tuveson DA. RAS in cellular transformation and senescence. Eur J Cancer. 2009;45(Suppl 1):211\u20136.","journal-title":"Eur J Cancer"},{"key":"8148_CR78","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/jb\/mvae079","volume":"177","author":"S Yamauchi","year":"2025","unstructured":"Yamauchi S, Takahashi A. Cellular senescence: mechanisms and relevance to cancer and aging. J Biochem. 2025;177:163\u20139.","journal-title":"J Biochem"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08148-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08148-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08148-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T02:03:38Z","timestamp":1780625018000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08148-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,18]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8148"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08148-4","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,18]]},"assertion":[{"value":"23 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by Suzhou Municipal Hospital Institutional Ethics Committee (Ethical Approval Number: K-2023-076-K01) and was conducted in accordance with the Declaration of Helsinki. All participants provided written informed consent prior to study enrollment. All animal protocols were approved by the Institutional Laboratory Animal Care and Use Committee at Soochow University (Ethical Approval Number: 202407A0273).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"739"}}